Both in Biotechnology
Cardiff Oncology vs ImageneBio
Over the past year CRDF returned −66.1% and IMA returned −50.4%; their daily moves had a correlation of 0.11.
CRDF −66.1% IMA −50.4%Growth of $1, one year, split-adjusted
| Metric | CRDF | IMA |
|---|---|---|
| Price | $0.7602 | $4.08 |
| Market cap | $59.1M | $46.3M |
| Today | −12.51% | −0.49% |
| 1 month | −30.3% | −11.5% |
| 6 months | −52.5% | −31.0% |
| Year to date | −72.9% | −40.9% |
| 1 year | −65.8% | −50.5% |
| Revenue growth (YoY) | −14.0% | — |
| Gross margin | 100.0% | — |
| Net margin | −8882.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 116.4× | — |
| Net cash | $34.5M | $136.2M |
| Dividend yield | — | — |
| Volatility (60d) | 75.5% | 34.6% |
| Short % of float | 17.7% | 0.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).